Rybelsus (Semaglutide) Tablet

Description

Description

This page contains brief details about the drug semaglutide, it’s indication, dosage & administaration, mechanism of action, related brands with strength, warnings and common side effects.

Date of Approval

Semaglutide was initially approved by the U.S. Food and Drug Administration (FDA) on December 5, 2017, for treating type 2 diabetes. Since then, it has also received additional approvals for its use in chronic weight management.

Mechanism of Action of Semaglutide

Semaglutide, a GLP-1 receptor agonist, exerts its therapeutic effects by mimicking the action of the naturally occurring hormone GLP-1. In diabetes management, this medication enhances insulin secretion, inhibits glucagon release, slows gastric emptying, and decreases hepatic glucose production. This medication effect leads to improved glycemic control and reduced HbA1c levels. Additionally, this medication promotes weight loss through increased satiety, decreased food intake, and modulation of gastric function. It has also demonstrated cardiovascular benefits, including potentially reducing major cardiovascular events.

Uses of Semaglutide

rSemaglutide is used to improve blood sugar control in type 2 diabetes and aid in weight management in individuals with obesity or overweight.

Semaglutide Dosage available

Semaglutide is typically administered as a subcutaneous injection at a convenient time once a week, on the same day each week. The injection can be given in the abdomen, thigh, or upper arm. These medication pens come with clear instructions on how to load the needle, dial the dose, and administer the injection. After injecting, dispose of the needle safely in a sharps container. Regular monitoring and follow-up with your healthcare provider are important to assess your progress and make any necessary adjustments to your treatment plan.